SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2019-07-31
👔
AbbVie Inc.
@ABBV_InsiderForm 4 Filing: Gosebruch Henry O Acquires $2.0M of $ABBV
INSIDER TRANSACTION
0 corporate issuer
AbbVie Inc.
Ticker: $ABBV
Transaction Value
$2.0M
Price/Share: $67.28
transaction date
2019-07-29
Shares: 30,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Gosebruch Henry O, holds the title of EVP, Chief Strategy Officer at AbbVie Inc..
On 2019-07-29, the insider transacted 30,000 shares.The shares were transacted at a weighted average price of $67.28 per share, resulting in a total market-relevant value of $2.0M.
Executive Summary Summary
Gosebruch Henry O (EVP, Chief Strategy Officer) purchase 30000 shares ABBV ($2,018,385)
Post-Transaction Position: 75,763 shares
SEC Accession No: 0001179110-19-008937 (CIK: 1659625)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.